Altis Labs
Toronto, CA · Founded 2019 · 31 employees on LinkedIn · 6 known investors
Find your way into Altis Labs
Altis Labs provides a web-based platform that applies AI models to medical imaging data to generate reproducible predictions and quantifications for clinical trials. It serves biopharma and clinical trial teams, helping them detect treatment effects, inform trial design and go/no-go decisions, and generate evidence for reimbursement.
Founders & leadership
FB
Felix Baldauf-LenscheninFounder & CEO
J
JohnCTO
Investors · 6
Creative Destruction Lab (CDL)Toronto · $50K – $250K
Debiopharm Innovation FundLausanne · $1M – $5M
FusionPalo Alto · $500K – $1M
OrbiMedNew York · $1M – $75M
Benchstrength PartnersreportedNew York
Also in the syndicate · 1
Benchstrengthlead
Funding
SEC filings, press & company announcements$6M disclosed across 1 round · 2023
- $6MseedJun 2023 · 3 sources
Benchstrength (lead), Debiopharm Innovation Fund (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Altis Labs do?
- Altis Labs provides a web-based platform that applies AI models to medical imaging data to generate reproducible predictions and quantifications for clinical trials. It serves biopharma and clinical trial teams, helping them detect treatment effects, inform trial design and go/no-go decisions, and generate evidence for reimbursement.
- Who are Altis Labs's investors?
- Altis Labs's investors include Creative Destruction Lab (CDL), Debiopharm Innovation Fund, Fusion, OrbiMed, Benchstrength Partners.
- How much funding has Altis Labs raised?
- Altis Labs has disclosed $6M raised across 1 round.
- Where is Altis Labs headquartered?
- Altis Labs is headquartered in Toronto, CA.